comparable to that of known coumarin-based fluorescence standards. Moreover, the new compounds were tested as potential antineurodegenerative agents via their ability to act as acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors. Compared to the commercial standards, only a few compounds demonstrated moderate AChE and BuChE activities. Moreover, the novel derivatives were tested for
使用多种光谱技术和 XRD 晶体学分离并充分表征了衍生自取代
香豆素-3-
羧酸的一系列新型
香豆素-
噻二唑杂化物。几种新型化合物在可见光区域显示出强烈的荧光,与已知的基于
香豆素的荧光标准相当。此外,这些新化合物通过它们作为
乙酰胆碱酯酶 (AChE) 和丁酰
胆碱酯酶 (BuChE)
抑制剂的能力被测试为潜在的抗神经退行性疾病。与商业标准相比,只有少数化合物表现出中等的 AChE 和 BuChE 活性。此外,还测试了这些新型衍
生物对一组病原细菌和真菌物种的抗菌活性。